A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma
McQuade, Jennifer L., Homsi, Jade, Torres-Cabala, Carlos A., Bassett, Roland, Popuri, Rashmi Murthy, James, Marihella L., Vence, Luis M., Hwu, Wen-JenVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-5193-9
Date:
December, 2018
File:
PDF, 1.14 MB
english, 2018